HealthSpan to Acquire Surgery Partners for $5.7B
HealthSpan Partners agrees to acquire outpatient surgical-care operator Surgery Partners in a $5.7 billion transaction, with Bain retaining an ownership stake.
Outpatient surgical care is attracting another major consolidation deal as large health systems seek to expand outside traditional hospital buildings.
What happened
HealthSpan Partners, an affiliate and supporting organisation of Bon Secours Mercy Health, agreed to acquire Surgery Partners in a transaction valued at approximately $5.7 billion including debt.
Under the agreement, shareholders other than Bain Capital affiliates will receive $23.50 per share in cash. Bain, already a major shareholder, will roll over its existing shares into equity in the acquiring entity and remain an investor alongside HealthSpan.
Surgery Partners operates more than 200 surgical facilities across roughly 30 US states. Its network includes ambulatory surgery centres, surgical hospitals and physician practices providing treatments across several medical specialties.
The deal is expected to close in the first quarter of 2027, subject to shareholder approval, regulatory clearance and other conditions. It has been agreed, not completed.
Why it matters
Healthcare delivery has been shifting toward outpatient settings for procedures that do not require a traditional hospital stay. These facilities can offer different cost structures and operating models while keeping patients closer to routine care.
For Bon Secours Mercy Health, the acquisition would add a substantial network of surgical locations and affiliated physicians. For Bain, rolling over its stake preserves exposure to future growth rather than representing a full cash exit.
The transaction is fundamentally a healthcare-services and infrastructure deal, not an acquisition of a healthcare software platform.
The bigger picture
Scaled healthcare operators are increasingly strategic buyers of assets historically associated with private-equity ownership and consolidation. The significance extends beyond the purchase price: it shows how ambulatory-care networks may become central to the operating footprint of large health systems. Integration, physician relationships and regulatory approval remain key considerations.